ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

Por Palomba, Grazia, Atzori, Francesco, Budroni, Mario, Ombra, MariaNeve, Cossu, Antonio, Sini, MariaCristina, Pusceddu, Valeria, Massidda, Bruno, Frau, Barbara, Notari, Francesca, Ionta, MariaTeresa, Palmieri, Giuseppe
Publicado em 2014

Molecular alterations in key-regulator genes among patients with T4 breast carcinoma

Por Massidda, Bruno, Sini, MariaCristina, Budroni, Mario, Atzori, Francesco, Deidda, MariaCristina, Pusceddu, Valeria, Perra, MariaTeresa, Sirigu, Paola, Cossu, Antonio, Palomba, Grazia, Ionta, MariaTeresa, Palmieri, Giuseppe
Publicado em 2010

Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients

Por IONTA, MARIA TERESA, PERRA, MARIA TERESA, ATZORI, FRANCESCO, MAXIA, CRISTINA, PUSCEDDU, VALERIA, DEMURTAS, PAOLO, DEIDDA, MARIA CRISTINA, PIRAS, FRANCA, FRAU, BARBARA, MURTAS, DANIELA, MINERBA, LUIGI, MASSIDDA, BRUNO, SIRIGU, PAOLA
Publicado em 2010

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia

Por Palomba, Grazia, Colombino, Maria, Contu, Antonio, Massidda, Bruno, Baldino, Giovanni, Pazzola, Antonio, Ionta, MariaTeresa, Capelli, Francesca, Trova, Vittorio, Sedda, Tito, Sanna, Giovanni, Tanda, Francesco, Budroni, Mario, Palmieri, Giuseppe, Cossu, Antonio
Publicado em 2012

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

Por Daponte, Antonio, Signoriello, Simona, Maiorino, Luigi, Massidda, Bruno, Simeone, Ester, Grimaldi, Antonio Maria, Caracò, Corrado, Palmieri, Giuseppe, Cossu, Antonio, Botti, Gerardo, Petrillo, Antonella, Lastoria, Secondo, Cavalcanti, Ernesta, Aprea, Pasquale, Mozzillo, Nicola, Gallo, Ciro, Comella, Giuseppe, Ascierto, Paolo Antonio
Publicado em 2013

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian canc...

Por Pignata, Sandro, De Placido, Sabino, Biamonte, Rosalbino, Scambia, Giovanni, Di Vagno, Giovanni, Colucci, Giuseppe, Febbraro, Antonio, Marinaccio, Marco, Vernaglia Lombardi, Alessandra, Manzione, Luigi, Cartenì, Giacomo, Nardi, Mario, Danese, Saverio, Valerio, Maria Rosaria, de Matteis, Andrea, Massidda, Bruno, Gasparini, Giampietro, Di Maio, Massimo, Pisano, Carmela, Perrone, Francesco
Publicado em 2006

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

Por Ruzzo, Annamaria, Graziano, Francesco, Galli, Fabio, Giacomini, Elisa, Floriani, Irene, Galli, Francesca, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Publicado no Sci Rep (2014)